Hua Xia Shi Bao·2025-11-25 06:37Core Viewpoint - WuXi AppTec's financial performance in the first three quarters of 2025 shows significant growth in net profit, largely driven by non-recurring gains, raising concerns about the sustainability of its profit structure [2][4][5]. Financial Performance - The company reported a revenue of 32.857 billion yuan, an 18.61% year-on-year increase, and a net profit of 12.076 billion yuan, which surged by 84.84% [2]. - Non-recurring gains contributed 2.553 billion yuan, primarily from the sale of shares in WuXi XDC Cayman Inc., with a total gain of 3.223 billion yuan [4]. - After excluding non-recurring gains, the net profit attributable to shareholders was 9.522 billion yuan, reflecting a lower growth rate of 42.51% compared to the overall net profit growth [4][5]. Revenue Structure - Revenue from domestic clients grew only 0.5% to 5.04 billion yuan, indicating stagnation, while revenue from U.S. clients increased by 31.9% to 22.15 billion yuan, and European revenue rose by 13.5% to 3.84 billion yuan [7]. - The company is heavily reliant on overseas clients, which poses risks due to geopolitical and trade policy uncertainties [7]. Business Segments - The chemical and TIDES segments showed strong growth, with increases of 29.28% and 121.1%, respectively, while testing services experienced a slight decline of 0.04% [8]. - Other business segments saw a decline of 10.47%, indicating weaknesses in certain areas [8]. Research and Development - R&D expenditures decreased to 826 million yuan, down 13.46% year-on-year, suggesting a reduction in investment in core business development [8]. Financial Pressure - Financial costs rose significantly, with expenses reaching 191 million yuan compared to a net gain of 62 million yuan in the previous year, and interest expenses increased to 227 million yuan [9]. - Short-term borrowings surged to 5.282 billion yuan, a 324.9% increase from the end of 2024 [9]. Order Backlog - The company reported a backlog of 59.88 billion yuan in ongoing business, a 41.2% increase year-on-year, but the order structure requires optimization [10]. - The addition of 621 new projects in the small molecule D&M pipeline indicates growth, but the conversion efficiency for later-stage projects remains low [10]. Future Outlook - The company faces challenges in reducing reliance on non-recurring gains and expanding its domestic market presence to mitigate geopolitical and financial pressures [11].